Histamine H4R Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-12904
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
The immunogen used to generate this antibody corresponds to human Histamine H4R.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
Centrifuge briefly prior to opening.
Scientific Data Images for Histamine H4R Antibody
Western Blot: Histamine H4R Antibody [NBP3-12904]
Western Blot: Histamine H4R Antibody [NBP3-12904] - Histamine H4R antibody detects Histamine H4R protein by western blot analysis. HL-60 whole cell extracts and membrane extracts (unboiled) (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with Histamine H4R antibody (NBP3-12904) diluted at 1:1000.Applications for Histamine H4R Antibody
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
PBS (pH 7), 20% Glycerol
Preservative
0.025% Proclin 300
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: Histamine H4R
Long Name
Histamine H4 Receptor
Alternate Names
AXOR35, BG26, GPCR105, GPRv53, HH4R, Histamine H4 R, HRH4, Pfi-013, SP9144
Gene Symbol
HRH4
Additional Histamine H4R Products
Product Specific Notices for Histamine H4R Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...